Ocular bacterial infections: current and future treatment options (Q36066237)

12 August 2017

1 reference

title

Ocular bacterial infections: current and future treatment options (English)

1 reference

12 August 2017

Regis P Kowalski

1

1 reference

PubMed ID

15757463

12 August 2017

Deepinder K Dhaliwal

series ordinal

2

1 reference

12 August 2017

1 February 2005

1 reference

Expert Review of Anti-infective Therapy

12 August 2017

1 reference

12 August 2017

3

1 reference

12 August 2017

1

1 reference

12 August 2017

131-139

1 reference

Binding of beta-lactam antibiotics to penicillin-binding proteins in methicillin-resistant Staphylococcus aureus.

12 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.1.131

Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.1.131

Vancomycin prophylaxis and emerging resistance: are ophthalmologists the villains? The heroes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.1.131

Prophylaxis of Endophthalmitis with Topical Povidone-iodine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.1.131

Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.1.131

Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.1.131

Moxifloxacin Efficacy and Vitreous Penetration in a Rabbit Model ofStaphylococcus aureusEndophthalmitis and Effect on Gene Expression of Leucotoxins and Virulence Regulator Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.1.131

Fluoroquinolone therapy in multiple-drug resistant staphylococcal keratitis after lamellar keratectomy in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.1.131

Endogenous endophthalmitis secondary to vancomycin-resistant enterococci infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.1.131

Infectious disease: changing antibiotic susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.1.131

Emerging ciprofloxacin-resistant Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.1.131

A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.1.131

Microbiologic evaluation of skin wounds: alarming trend toward antibiotic resistance in an inpatient dermatology service during a 10-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.1.131

Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.1.131

Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.1.131

21 January 2018

Identifiers

DOI

10.1586/14787210.3.1.131

1 reference

12 August 2017

1 reference

PubMed ID

15757463